SLC29A2 antibody is human specific. SLC29A2 antibody is predicted to not cross-react with other SLC29 proteins.
Purification
SLC29A2 antibody is affinity chromatography purified via peptide column.
Immunogène
SLC29A2 antibody was raised against a 19 amino acid peptide near the center of human SLC29A2. The immunogen is located within amino acids 250 - 300 of SLC29A2.
SLC29A2
Reactivité: Humain, Souris, Rat
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
Alexa Fluor 350
Indications d'application
SLC29A2 antibody can be used for detection of SLC29A2 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 2.5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
Antibody validated: Western Blot in human samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
SLC29A2 antibody is supplied in PBS containing 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C,4 °C
Stockage commentaire
SLC29A2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Antigène
SLC29A2
(Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2))
anticorps DER12, anticorps ENT2, anticorps HNP36, anticorps Der12, anticorps Ent2, anticorps Hnp36, anticorps ent2, anticorps der12, anticorps hnp36, anticorps MGC82995, anticorps DKFZp468L038, anticorps zgc:110527, anticorps solute carrier family 29 member 2, anticorps solute carrier family 29 (nucleoside transporters), member 2, anticorps solute carrier family 29 (equilibrative nucleoside transporter), member 2 L homeolog, anticorps solute carrier family 29 (equilibrative nucleoside transporter), member 2, anticorps SLC29A2, anticorps Slc29a2, anticorps slc29a2.L, anticorps slc29a2
Sujet
SLC29A2 is a member of the equilibrative nucleoside transporter family which plays a key role in nucleoside and nucleobase uptake for salvage pathways of nucleotide synthesis (1,2). SLC29A2 is a transmembrane glycoprotein that mediates the cellular uptake of nucleosides from the surrounding medium (3). As a nucleoside transporter, SLC29A2 plays an important role in the uptake of nucleoside-based anti-cancer drugs, polymorphisms of point mutations in the gene encoding this protein may affect the efficacy of these drugs (4).